Optimal Angiographic Goal and Number of Passes for Octogenarians Undergoing Endovascular Stroke Thrombectomy

医学 冲程(发动机) 血管内治疗 放射科 外科 动脉瘤 机械工程 工程类
作者
Huanwen Chen,Marco Colasurdo,Chad Schrier,Jose Marino,Michael Phipps,Marcella A. Wozniak,Carolyn Cronin,Prachi Mehndiratta,John W. Cole,Timothy Miller,Jacob Cherian,Dheeraj Gandhi,Seemant Chaturvedi,Gaurav Jindal
出处
期刊:World Neurosurgery [Elsevier BV]
卷期号:186: e283-e289 被引量:5
标识
DOI:10.1016/j.wneu.2024.03.123
摘要

The optimal recanalization goal and number of endovascular thrombectomy (EVT) passes for elderly patients with large vessel occlusion (LVO) strokes is unclear.Consecutive patients 80 years or older undergoing EVT were identified from 2016 to 2022 at a single center. Clinical information, procedural details, and modified treatment in cerebral ischemia (mTICI) scores were collected. Primary outcome was modified Rankin scale (mRS) at 90 days. Bivariate and multivariable analyses were conducted to assess associations between mTICI scores, EVT passes, and 90-day outcomes.126 patients were identified. At 90 days, mTICI 2b recanalization resulted in high rates of poor outcomes (8.7% functional independence and 60.9% mortality) not significantly different from mTICI 0, 1 or 2a (median mRS 6 vs. 6, p=0.61). Complete recanalization (mTICI 2c or 3) led to significantly better mRS outcomes at 90 days compared to mTICI 2b (median mRS 4 vs. 6, adjusted p=0.038), with 26.8% functional independence and 37.8% mortality. In multivariable analysis, complete recanalization was significantly associated with better 90-day outcomes than mTICI 2b or lower recanalization (OR 4.24 [95%CI 1.46-12.3]; p=0.002), while the number of passes was not independently associated with worse outcomes (p=0.98).For octogenarians, mTICI 2b recanalization yields limited clinical benefit and results in poor 90-day outcomes. In contrast, complete recanalization is independently associated with significantly better outcomes. Thus, once the decision is made to pursue EVT in the elderly, mTICI 2c or better recanalization should be the angiographic goal. Providers should not withhold thrombectomy passes based on age alone.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Lucas应助科研通管家采纳,获得10
刚刚
核桃应助科研通管家采纳,获得40
刚刚
dde应助科研通管家采纳,获得10
刚刚
酷波er应助科研通管家采纳,获得10
刚刚
斯文败类应助科研通管家采纳,获得10
刚刚
dde应助科研通管家采纳,获得10
刚刚
渡人舟举报乐乐宝求助涉嫌违规
2秒前
杭三问发布了新的文献求助10
3秒前
NEM嬛嬛驾到完成签到,获得积分10
3秒前
勤劳翰发布了新的文献求助10
3秒前
微风完成签到 ,获得积分10
3秒前
情怀应助dd采纳,获得10
4秒前
无限的晓绿应助积极行天采纳,获得10
4秒前
5秒前
大模型应助ysh采纳,获得10
6秒前
东方元语应助勤劳翰采纳,获得20
8秒前
8秒前
深情安青应助维E真采纳,获得10
8秒前
zuzu应助维E真采纳,获得10
8秒前
FashionBoy应助维E真采纳,获得10
8秒前
斯文败类应助维E真采纳,获得10
9秒前
奔跑应助维E真采纳,获得10
9秒前
彭于晏应助维E真采纳,获得10
9秒前
科研通AI6.2应助乘风采纳,获得10
10秒前
香蕉觅云应助jinzhen采纳,获得10
12秒前
13秒前
14秒前
14秒前
lzzzz发布了新的文献求助10
15秒前
ICY完成签到,获得积分10
15秒前
16秒前
Akim应助蔡宇滔采纳,获得10
17秒前
高大代容发布了新的文献求助10
19秒前
赘婿应助执着的过客采纳,获得10
19秒前
hongxing liu完成签到,获得积分10
19秒前
毗昙发布了新的文献求助10
19秒前
19秒前
20秒前
大个应助贾硕士采纳,获得10
20秒前
顾矜应助张淑涵采纳,获得10
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Reducing Compassion Fatigue, Secondary Traumatic Stress and Burnout 600
China Pluperfect I: Epistemology of Past and Outside in Chinese Art 520
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
Mammalian Synthetic Biology 500
Auslegungsgeschichte 500
Cosmos as Art Object: Studies in Plato's Timaeus and Other Dialogues 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7638098
求助须知:如何正确求助?哪些是违规求助? 9211411
关于积分的说明 19758652
捐赠科研通 7205015
什么是DOI,文献DOI怎么找? 3275778
关于科研通互助平台的介绍 2437385
邀请新用户注册赠送积分活动 2272954